112 related articles for article (PubMed ID: 2645508)
1. [Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities].
Pellkofer M; Paulig M
Med Klin (Munich); 1989 Jan; 84(1):5-8. PubMed ID: 2645508
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
Smolenski C; Muff S; Smolenski-Kautz S
Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
[TBL] [Abstract][Full Text] [Related]
3. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
Groves L; Shellenberger MK; Davis CS
Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
[TBL] [Abstract][Full Text] [Related]
4. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
[TBL] [Abstract][Full Text] [Related]
5. Ketazolam treatment for spasticity: double-blind study of a new drug.
Basmajian JV; Shankardass K; Russell D; Yucel V
Arch Phys Med Rehabil; 1984 Nov; 65(11):698-701. PubMed ID: 6149738
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
[TBL] [Abstract][Full Text] [Related]
7. Flexor reflex for assessment of common interneurone activity in spasticity.
Milanov IG
Electromyogr Clin Neurophysiol; 1992 Dec; 32(12):621-9. PubMed ID: 1493777
[TBL] [Abstract][Full Text] [Related]
8. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
Vakhapova V; Auriel E; Karni A
Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
[TBL] [Abstract][Full Text] [Related]
9. Comparative profile of tizanidine in the management of spasticity.
Lataste X; Emre M; Davis C; Groves L
Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
[TBL] [Abstract][Full Text] [Related]
10. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen.
Stien R; Nordal HJ; Oftedal SI; Slettebø M
Acta Neurol Scand; 1987 Mar; 75(3):190-4. PubMed ID: 3554879
[TBL] [Abstract][Full Text] [Related]
11. Ketazolam once daily for spasticity: double-blind cross-over study.
Basmajian JV; Shankardass K; Russell D
Arch Phys Med Rehabil; 1986 Aug; 67(8):556-7. PubMed ID: 2874780
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of tetrazepam action on spasticity.
Milanov I
Acta Neurol Belg; 1992; 92(1):5-15. PubMed ID: 1347669
[TBL] [Abstract][Full Text] [Related]
13. Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy.
Roussan M; Terrence C; Fromm G
Pharmatherapeutica; 1985; 4(5):278-84. PubMed ID: 3906673
[TBL] [Abstract][Full Text] [Related]
14. [Tetrazepam in the treatment of painful muscle spasms].
Jovicić A; Ivanisević V
Vojnosanit Pregl; 1991; 48(5):394-9. PubMed ID: 1686339
[TBL] [Abstract][Full Text] [Related]
15. Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis.
Eyssette M; Rohmer F; Serratrice G; Warter JM; Boisson D
Curr Med Res Opin; 1988; 10(10):699-708. PubMed ID: 3286128
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal baclofen for treatment of intractable spinal spasticity.
Abel NA; Smith RA
Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
[TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of spasticity].
Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
[TBL] [Abstract][Full Text] [Related]
19. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
Wallace JD
Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
[TBL] [Abstract][Full Text] [Related]
20. An approach to switching patients from baclofen to tizanidine.
Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
